Zirabev 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung
7680675010028
CH-67501
Konzentrat
Associated product:
ZIRABEV conc perf 400 mg/16ml vial 16 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
9.29 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1063.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2020
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 67501
- Drug name
- Zirabev, Konzentrat zur Herstellung einer lnfusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/05/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- ZIRABEV conc perf 400 mg/16ml vial 16 ml
- Description (DE)
- ZIRABEV Inf Konz 400 mg/16ml Vial 16 ml
- Market launch
- 10/05/2020
- Narcotic (BTM)
- No
Other package sizes (1)
ZIRABEV conc perf 100 mg/4ml vial 4 ml
1 DUR
GTIN: 7680675010011